Skip to content
2000
Volume 23, Issue 9
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Amyloid beta peptide (Aβ) is recognised as a main feature of Alzheimer’s disease (AD). Increasing evidence suggests that small soluble oligomers of Aβ are the toxic form of the peptide and may instigate AD. Different factors including some key residues within Aβ molecule, the cell membrane, prion protein and metals play important roles in developing AD. Significant progress has been made to understand these factors and elucidate the mechanism of cytotoxicity of Aβ. This review summarizes recent findings in the area of Aβ and AD research, and this current knowledge could enable medicinal chemists to design and develop therapeutics to treat AD.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867323666160229113911
2016-03-01
2025-06-22
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867323666160229113911
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test